Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors

Background: Cancer is a leading cause of death worldwide. Extensive research over decades has led to the development of therapies that inhibit oncogenic signaling pathways. The mammalian target of rapamycin (mTOR) signaling pathway plays an important role in the development of many cancers. Several...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Xia, Yiqun, Chen, Jundixia, Yu, Yun, Wu, Fengjiao, Shen, Xin, Qiu, Chenyu, Zhang, Tingting, Hong, Lin, Zheng, Peisen, Shao, Rongrong, Xu, Chenxin, Wu, Fang, Chen, Wei, Xie, Congying, Cui, Ri, Zou, Peng
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2021
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7977446/
https://ncbi.nlm.nih.gov/pubmed/33754064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.52077
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados